Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

ARKGvsPTHETF Comparison

ETF 1
ARKG

ARK Genomic Revolution ETF

This fund is part of
BioTech & Genomics
+0.64%
VS
ETF 2
PTH

Invesco DWA Healthcare Momentum ETF

This fund is part of
US Health Care
+1.78%

ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Invesco DWA Healthcare Momentum ETF (PTH) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Healthcare. ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.72% for PTH. ARKG is up 29.7% year-to-date (YTD) with +$30M in YTD flows. PTH performs worse with 16.59% YTD performance, and +$88M in YTD flows. Run a side-by-side ETF comparison of ARKG and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

ARKG vs PTH performance and flow charts

Performance

-10.0-5.00.0%Jun 29Jul 6Jul 13Jul 20Jul 27

Cumulative Flows

0 M50 M100 MJun 29Jul 6Jul 13Jul 20Jul 27

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/28/2026
1M3MYTD1Y3Y5Y
Perf.
ARKG
PTH
-10.72%-2.69%
+27.99%+14.59%
+29.70%+16.59%
+47.48%+57.01%
+1.63%+54.03%
-55.32%+5.14%
Flows
ARKG
PTH
+$9M+$102M
+$67M+$94M
+$30M+$88M
-$36M+$93M
-$567M+$25M
-$2.54B-$192M
Volatility and drawdown
3M1Y3Y5Y
Volatility
ARKG
PTH
+44.74%+28.88%
+42.62%+24.62%
+43.39%+25.61%
+45.95%+25.55%
Max drawdown
ARKG
PTH
-13.27%-8.31%
-27.52%-11.91%
-51.67%-27.71%
-79.29%-50.10%
Max drawdown duration
ARKG
PTH
22d41d
126d140d
1058d353d
1818d1756d
Trading data

Create an account to view trading data

Join for free
ARKG
PTH
Last sale
7/29/2026 at 6:11 PM
$37.98
$57.03
Previous close
07/28/2026
$37.82
$57.98
Consolidated volume
07/28/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
ARKG
PTH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/29/2026 at 6:11 PM
Live
Closed
ARKG
PTH
Last price
$37.98
$57.03
1D performance
+0.42%
-1.64%
AuM$1.52 B$229.53 M
E/R0.75%0.72%
Characteristics
ARKG
PTH
Management strategyActivePassive
ProviderArk InvestmentInvesco
Benchmark-Dorsey Wright Healthcare Technical Leaders Index
N° of holdings3157
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateApril 2, 2019October 12, 2006
ESGNoNo
Advertisement
Exposure

Countries

ARKG
USA
86.99%
Other
13.01%
PTH
USA
92.25%
Other
7.75%

Sectors

ARKG
Healthcare
96.93%
Other
3.07%
PTH
Healthcare
100%
Other
0%

Diversification

ARKG

Total weight of top 15 holdings out of 15

74.95%
PTH

Total weight of top 15 holdings out of 15

43.88%

Top 15 holdings

Data as of June 30, 2026
ARKG
Twist Bioscience Corp.
9.15%
Tempus AI, Inc.
7.64%
Absci Corp.
7.01%
10X Genomics, Inc.
7.00%
CRISPR Therapeutics AG
6.56%
Personalis, Inc.
6.19%
Beam Therapeutics, Inc.
4.34%
Guardant Health, Inc.
4.28%
Natera, Inc.
4.11%
Illumina, Inc.
3.98%
Veracyte, Inc.
3.24%
CareDx, Inc.
3.08%
Recursion Pharmaceuticals, Inc.
2.85%
Eli Lilly & Co.
2.81%
Compass Pathways Plc
2.70%
PTH
Roivant Sciences Ltd.
4.95%
Praxis Precision Medicines, Inc.
4.66%
Tango Therapeutics, Inc.
3.70%
SELLAS Life Sciences Group, Inc.
3.36%
United Therapeutics Corp.
2.91%
Tenet Healthcare Corp.
2.89%
Axsome Therapeutics, Inc.
2.74%
BrightSpring Health Services, Inc.
2.54%
Liquidia Corp.
2.52%
Moderna, Inc.
2.49%
Ionis Pharmaceuticals, Inc.
2.30%
Erasca, Inc.
2.29%
HCA Healthcare, Inc.
2.23%
Twist Bioscience Corp.
2.21%
Protagonist Therapeutics, Inc.
2.08%
Frequently asked questions about ARKG and PTH

How have the ARKG and PTH ETFs performed in 2026?

As of July 28, 2026, ARKG is up 29.7% year-to-date (YTD), while PTH has returned 16.59%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or PTH?

Year-to-date, the ARKG ETF saw +$30M in flows, compared to +$88M for PTH.

Which ETF is more volatile: ARKG or PTH?

Over the past year, ARKG had a volatility of 42.62%, while PTH experienced 24.62%.

Which ETF is bigger: ARKG or PTH?

As of July 28, 2026, ARKG holds $1.52 B in assets under management (AUM), while PTH manages $229.53 M.

What sectors do the ARKG and PTH ETFs invest in?

ARKG leans toward sectors like Healthcare. Meanwhile, PTH focuses on Healthcare.

What are the top holdings of the ARKG ETF and PTH ETF?

ARKG top holdings include Twist Bioscience Corp., Tempus AI, Inc. and Absci Corp.. PTH holds in its top three: Roivant Sciences Ltd., Praxis Precision Medicines, Inc. and Tango Therapeutics, Inc..

Which ETF is more diversified: ARKG or PTH?

ARKG holds 31 securities with 74.95% of its assets in the top 15. PTH has 57 securities and a top 15 weight of 43.88%.

Advertisement
Latest news about ARKG & PTH
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up